Celldex Therapeutics (CLDX) Q1 2022 Earnings

28FebConfirmed
Q2 2021
Q3 2021
Q4 2021
Q1 2022
-0.45
-0.41
-0.38
-0.34

Details

Expected EPS
-0.42
Actual EPS
-0.43
Surprise EPS
-0.01
Surprise Percent
+2.38%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.43 per share for Q1 2022.

0 Comments

Share your thoughts